Skip to main content
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · TLX ISIN · AU000000TLX2 ASX Manufacturing
Open in API
Filings indexed 989 across all filing types
Latest filing 2022-01-30 Share Issue/Capital Cha…
Country US United States of America
Listing ASX TLX

About Telix Pharmaceuticals Ltd

https://telixpharma.com/

Telix Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, an approach known as 'theranostics'. The company utilizes targeted radiation to both image and treat various forms of cancer. Its extensive clinical pipeline and portfolio address key areas in oncology, including urologic (prostate and kidney), neurologic (glioma), and musculoskeletal cancers, as well as applications in bone marrow conditioning. Telix has secured global regulatory approvals for its prostate cancer imaging agent and supports its products with a robust global supply, manufacturing, and distribution network. The company is actively engaged in numerous clinical trials worldwide to expand its theranostic platform.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - TLX 6 pages 28.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by Telix Pharmaceuticals Limited. It references previous announcements (Appendix 3B) related to the issue of securities and provides details about the number and type of securities to be quoted, issue dates, and issued capital following quotation. The document is an official announcement to the ASX regarding the quotation of securities already issued, not a financial report or earnings release. It is not a report itself but an announcement related to capital market activities, specifically the quotation of securities. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital changes.
2022-01-30 English
Notice of change of interests of substantial holder 2 pages 76.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in Telix Pharmaceuticals Limited, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2022-01-30 English
Cleansing Notice under S708A(5)(e) Corporations Act 2001 1
Share Issue/Capital Change Classification · 100% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 regarding shares issued under an institutional placement. It details the issuance of shares, the legal basis for the notice, and compliance with disclosure obligations. The content focuses on capital raising and share issuance rather than financial results, management changes, or other report types. The document length is short (1631 characters) and it is a formal announcement of a share issue under regulatory requirements. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2022-01-30 English
Notice of change of interests of substantial holder 2 pages 66.4KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder filed under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder in Telix Pharmaceuticals Limited, including dates, share quantities, and nature of changes. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding changes.
2022-01-30 English
App 3Y Change of Directors Interest Notice - A Kluge 3 pages 214.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details a director's personal share transactions, including the number of shares disposed and held before and after the transaction. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure of insider trading by a director. The content focuses exclusively on the director's share dealings and does not include financial results, management commentary, or other report types. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters and is a direct notice, not an announcement of a report. Therefore, the correct classification is DIRS with high confidence.
2022-01-30 English
Despatch of SPP Booklet to Eligible Shareholders 12 pages 856.2KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX release dated 31 January 2022 from Telix Pharmaceuticals Limited regarding the despatch of a Share Purchase Plan (SPP) Booklet to eligible shareholders. It details the terms, conditions, and key dates of the SPP, including the offer price, maximum subscription amounts, eligibility criteria, and application instructions. The document is a detailed booklet intended to inform shareholders about the opportunity to purchase new shares under the SPP. It is not a financial report, earnings release, or regulatory filing but rather a capital raising communication focused on a share issue. Therefore, the document fits the category of a Share Issue/Capital Change announcement.
2022-01-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.